Therefore, to elucidate the diagnostic value of serum AnxA2 in different breast cancer subtypes, ROC curve analysis based on serum AnxA2 levels of ER+, HER2+ and TNBC breast cancer patients compared to normal healthy patients was evaluated (Figure 3B). This evidence concerns the gene ANXA2 and breast carcinoma.